SCHEMBL6764213

SCHEMBL6764213

CCOC(=O)/C(C)=C(\C)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
LMNA P02545 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GLO1 Q04760 1/20 0.43
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
SOAT1 P35610 1/20 0.37
EGLN1 Q9GZT9 1/20 0.36
HPGD P15428 1/20 0.36
TRPA1 O75762 1/20 0.34
CYP2D6 P10635 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GLA P06280 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764215 1.00 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL6760239 0.83 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL6760237 0.83 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL20262463 0.82 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL27314897 0.82 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL10009719 0.80 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL16160166 0.80 GLO1 (0.47) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL10009721 0.80 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL11141816 0.80 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10GLO1MAPT
SCHEMBL5611940 0.80 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10GLO1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105890-A1 Novel condensed imidazole derivative DAINIPPON SUMITOMO PHARMA CO., LTD 2007-05-10 US disclosed
US-6723313-B2 FRAGRANCE, AN AROMA, OR A FLAVORING AGENT FOR PERFUMES, DETERGENTS, SOAPS, CREAMS, SHAMPOOS, HAIR CONDITIONERS, FOODS GIVAUDAN SA (CH) 2004-04-20 US disclosed
US-20020176838-A1 2-,5-,6-,7-,8-substituted oct-2-en-4-ones GIVAUDAN SA 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105890-A1 Novel condensed imidazole derivative DPP4, DPP7, DPP3 ALDH1A1 63/4885LMNA 4616/4885HSD17B10 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.